Mcguire J L, Awouters F, Niemegeers C J
Arch Int Pharmacodyn Ther. 1978 Nov;236(1):51-9.
The antidiarrheal drugs loperamide and diphenoxylate were tested for their ability to potentiate central nervous system depression induced by ethanol in mice and nethohexital in rats. Oral diphenoxylate potentiated the loss of righting reflex (hypnosis) at 10 mg/kg in mice and at 5 mg/kg in rats, doses which were considerably lower than those required to induce morphine-like behavior in mice and rats. Oral loperamide did not potentiate hypnosis. Increased incidence and duration of hypnosis was observed with loperamide only at very high, nearly toxic doses (100 mg/kg in mice and 80 mg/kg in rats) and these doses induced only nonspecific central nervous system depression. The failure of loperamide to potentiate the action of hypnotics confirms data from clinical trials which showed that loperamide is essentially free of central depressant effects when given orally.
对止泻药洛哌丁胺和地芬诺酯进行了测试,以检验它们增强乙醇诱导的小鼠中枢神经系统抑制以及戊巴比妥诱导的大鼠中枢神经系统抑制的能力。口服地芬诺酯可增强小鼠在10毫克/千克剂量、大鼠在5毫克/千克剂量时的翻正反射消失(催眠),这些剂量远低于诱导小鼠和大鼠出现吗啡样行为所需的剂量。口服洛哌丁胺不会增强催眠作用。仅在非常高的、接近中毒剂量(小鼠为100毫克/千克,大鼠为80毫克/千克)时观察到洛哌丁胺会增加催眠的发生率和持续时间,而这些剂量仅诱导非特异性中枢神经系统抑制。洛哌丁胺不能增强催眠药的作用,这一结果证实了临床试验的数据,即口服洛哌丁胺基本没有中枢抑制作用。